Beranda › Gagal Jantung › Texas › Austin
Uji klinis Gagal Jantung di Austin, TX
18 studi untuk Gagal Jantung mencari peserta di lokasi sekitar Austin (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Alleviant ALLAY-HFrEF Study
Menerima peserta
- Austin Heart, Austin
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Menerima pesertaFase 3
- Austin Heart, Austin
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Menerima pesertaFase 3
- Research Site, Austin
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Menerima pesertaFase 3
- CON-10015 Austin, TX Investigational Site, Austin
The WiSE®-UP Study (The WiSE System Utilization & Performance Study)
Menerima pesertaStudi observasional
- Texas Cardiac Arrhythmia Research Foundation, Austin
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Menerima pesertaFase 3
- Austin, TX Investigative Site 10015, Austin
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Dell Children's Medical Center of Central Texas, Austin
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Menerima pesertaStudi observasional
- Austin, Austin
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Menerima pesertaFase 3
- Tenax Investigational Site, Austin
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Menerima pesertaFase 3
- Austin Heart, Austin
Alleviant ALLAY-HF Study
Menerima peserta
- Austin Heart, Austin
Assessment of CCM in HF With Higher Ejection Fraction
Menerima peserta
- Ascension Seton, Austin
- Austin Heart, Austin
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
Menerima pesertaFase 3
- FIN-10015 Austin, TX Investigational Site, Austin
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Menerima peserta
- Austin Heart, Austin
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Menerima peserta
- Ascension Texas Cardiovascular, Austin
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Texas Cardiac Arrhythmia Research Foundation, Austin
Sensor-controlled Digital Game for Heart Failure Self-management: A Clinical Trial
Menerima peserta
- The University of Texas Austin, Austin
HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
Menerima pesertaStudi observasional
- Austin Heart, Austin
Uji klinis Gagal Jantung di kota lain
- New York City, NY51 studi
- Boston, MA44 studi
- Dallas, TX42 studi
- Houston, TX36 studi
- Cleveland, OH33 studi
- Chicago, IL31 studi
- Philadelphia, PA31 studi
- San Francisco, CA29 studi
- St. Louis, MO26 studi
- Durham, NC26 studi
- Kansas City, MO25 studi
- Atlanta, GA25 studi
Studi lain di Austin
- Kanker Paru Non-Sel Kecil30 studi
- Kanker (semua jenis)20 studi
- Obesitas20 studi
- Kanker Metastatik19 studi
- Kanker Kolorektal19 studi
- Kanker Payudara18 studi
- Kelebihan Berat Badan18 studi
- Kanker Ovarium17 studi
- Kanker Endometrium15 studi
- Kanker Prostat15 studi
- Depresi14 studi
- Kanker Payudara Triple-Negatif13 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.